| Eligibility |
Inclusion Criteria:
- Male or Female
- Age 18 through 30 years at the time of consent
- Binocular vision
- Willing and able to give informed consent and follow all study procedures and
requirements
- Fluent in English
Exclusion Criteria:
- Spherical correction > +4D or < -5D, astigmatism < -2.5D.
- Using anticholinergic medications (including first-generation antihistamines) or other
medications known to affect visual acuity within the greater of 3 days or 5 half-lives
prior to enrolling in this study
- Using an investigational drug or approved therapy for investigational use within the
greater of 3 days or 5 half-lives prior to enrolling in this study
- Has initiated any new medication in the past 2 weeks that, in the best medical
judgment of the investigator, would impact their participation in the study or ability
to use EyeQue devices
- Reported or observed eye disease or pathology, including but not limited to:
- Glaucoma
- Cataracts
- Macular degeneration
- Eye infection
- Keratoconus
- Diabetic neuropathy/retinopathy
- Cytomegalovirus retinitis
- Color blindness (any color deficiency)
- Diabetic macular edema
- Amblyopia
- Chronic or acute uveitis (cells and/or flare in anterior chamber)
- Strabismus (exotropia, esotropia, and hypertropia)
- Macular hole
- Eye surgery within the last 12 months (including Lasik or lens replacement)
- Subject does not have the physical dexterity to properly operate the EyeQue
VisionCheck device or the EyeQue app on the smartphone in the investigator's opinion
- PD smaller than 50mm or larger than 75mm.
- Any self-reported mental illness or condition, including but not limited to:
claustrophobia, fear of simulators, nyctophobia.
- Any self-reported neurological diseases, including but not limited to: epilepsy,
Alzheimer's, nystagmus.
|
